Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Strategic Asset Allocation Index
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Strategic Asset Allocation Index of 21.7% as of September 2022. Strategic assets (PP&E of CN¥224.54 Million plus long-term investments of CN¥-) total CN¥224.54 Million, measured against net assets of CN¥1.03 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 300942 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Shenzhen Bioeasy Biotechnology Co. Ltd. Strategic Asset Allocation Index (2017–2021)
This chart shows how Shenzhen Bioeasy Biotechnology Co. Ltd.'s Strategic Asset Allocation Index has evolved across 5 annual periods from 2017 to 2021. As of September 2022, the index stands at 21.7%, representing strategic assets of CN¥224.54 Million against net assets of CN¥1.03 Billion CNY. See 300942 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Shenzhen Bioeasy Biotechnology Co. Ltd. (2017–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen Bioeasy Biotechnology Co. Ltd. from 2017 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Shenzhen Bioeasy Biotechnology Co. Ltd..
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 15.2% | CN¥143.44 Million | CN¥143.44 Million | CN¥- | CN¥946.58 Million | ▲ +7.0 pp |
| 2020 | 8.2% | CN¥44.89 Million | CN¥44.89 Million | CN¥- | CN¥548.98 Million | ▲ +2.6 pp |
| 2019 | 5.6% | CN¥29.41 Million | CN¥29.41 Million | CN¥- | CN¥528.32 Million | ▼ -1.5 pp |
| 2018 | 7.1% | CN¥15.73 Million | CN¥15.73 Million | CN¥- | CN¥222.62 Million | ▼ -4.2 pp |
| 2017 | 11.2% | CN¥12.87 Million | CN¥12.87 Million | CN¥- | CN¥114.60 Million | — |